Nicholas Investment Partners, LP Bridge Bio Pharma, Inc. Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

A detailed history of Nicholas Investment Partners, LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 35,644 shares of BBIO stock, worth $845,475. This represents 0.1% of its overall portfolio holdings.

Number of Shares

35,644

Holding current value

$845,475

% of portfolio

0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.91 - $31.3 $852,248 - $1.12 Million	35,644 New	35,644 $907,000
Q1 2022 May 10, 2022	SELL	$7.34 - $17.16 $2.16 Million - $5.06 Million	-294,879 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $99,540 - $467,177	8,747 Added 3.06%	294,879 $4.92 Million
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $7.77 Million - $10.7 Million	-165,850 Reduced 36.69%	286,132 $13.4 Million
Q2 2021 Aug 10, 2021	SELL	$46.47 - $63.93 $1.75 Million - $2.41 Million	-37,641 Reduced 7.69%	451,982 $27.6 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $4.32 Million - $5.63 Million	77,852 Added 18.91%	489,623 $30.2 Million
Q4 2020 Feb 11, 2021	BUY	$38.38 - $71.11 $4.56 Million - $8.45 Million	118,789 Added 40.54%	411,771 $29.3 Million
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $6.52 Million - $10.1 Million	239,626 Added 449.11%	292,982 $11 Million
Q2 2020 Aug 12, 2020	SELL	$22.22 - $35.69 $157,050 - $252,256	-7,068 Reduced 11.7%	53,356 $1.74 Million
Q1 2020 May 13, 2020	BUY	$16.11 - $36.23 $654,307 - $1.47 Million	40,615 Added 205.03%	60,424 $1.75 Million
Q4 2019 Feb 13, 2020	BUY	$17.96 - $46.63 $172,847 - $448,767	9,624 Added 94.49%	19,809 $694,000
Q3 2019 Nov 13, 2019	BUY	$20.13 - $32.38 $205,024 - $329,790	10,185 New	10,185 $219,000

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.52B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account

Nicholas Investment Partners, LP Bridge Bio Pharma, Inc. Transaction History